These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24093513)

  • 1. Augmented cytotoxicity of hydroxycamptothecin-loaded nanoparticles in lung and colon cancer cells by chemosensitizing pharmaceutical excipients.
    Zaki NM
    Drug Deliv; 2014 Jun; 21(4):265-75. PubMed ID: 24093513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and properties of hydroxycamptothecin-loaded nanoparticles made of amphiphilic copolymer and normal polymer.
    Wang J; Wang R; Li LB
    J Colloid Interface Sci; 2009 Aug; 336(2):808-13. PubMed ID: 19520376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
    Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
    J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery.
    Zu Y; Meng L; Zhao X; Ge Y; Yu X; Zhang Y; Deng Y
    Int J Nanomedicine; 2013; 8():1207-22. PubMed ID: 23569373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEG-chitosan-coated iron oxide nanoparticles with high saturated magnetization as carriers of 10-hydroxycamptothecin: preparation, characterization and cytotoxicity studies.
    Qu JB; Shao HH; Jing GL; Huang F
    Colloids Surf B Biointerfaces; 2013 Feb; 102():37-44. PubMed ID: 23000675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect.
    Wang A; Li S
    BMC Biotechnol; 2008 May; 8():46. PubMed ID: 18454874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of pH responsive polymeric nanoparticles of SN-38 for colon cancer.
    Prasad S; Dangi JS
    Artif Cells Nanomed Biotechnol; 2016 Dec; 44(8):1824-1834. PubMed ID: 26540095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
    Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
    J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
    Zhang Z; Feng SS
    Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors.
    Jain A; Jain SK
    Eur J Pharm Sci; 2008 Dec; 35(5):404-16. PubMed ID: 18824095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evaluation of 10-hydroxycamptothecin-loaded poly (n-butyl cyanoacrylate) nanoparticles prepared by miniemulsion polymerization.
    Jin X; Asghar S; Zhu X; Chen Z; Tian C; Yin L; Ping Q; Xiao Y
    Colloids Surf B Biointerfaces; 2018 Feb; 162():25-34. PubMed ID: 29145001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid nanoparticles loaded with 7-ethyl-10-hydroxycamptothecin-phospholipid complex: in vitro and in vivo studies.
    Liu H; Lu H; Liao L; Zhang X; Gong T; Zhang Z
    Drug Deliv; 2015; 22(6):701-9. PubMed ID: 24625262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer.
    Zhang X; Gan Y; Gan L; Nie S; Pan W
    J Pharm Pharmacol; 2008 Aug; 60(8):1077-87. PubMed ID: 18644200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
    Alibolandi M; Taghdisi SM; Ramezani P; Hosseini Shamili F; Farzad SA; Abnous K; Ramezani M
    Int J Pharm; 2017 Mar; 519(1-2):352-364. PubMed ID: 28126548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
    Yang R; Shim WS; Cui FD; Cheng G; Han X; Jin QR; Kim DD; Chung SJ; Shim CK
    Int J Pharm; 2009 Apr; 371(1-2):142-7. PubMed ID: 19118614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin.
    Yuan Y; Wen J; Tang J; Kan Q; Ackermann R; Olsen K; Schwendeman A
    Int J Nanomedicine; 2016; 11():6229-6238. PubMed ID: 27920529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.
    Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T
    J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral delivery of solid lipid nanoparticles surface decorated with hyaluronic acid and bovine serum albumin: A novel approach to treat colon cancer through active targeting.
    Ahmed SS; Baba MZ; Wahedi U; Koppula J; Reddy MV; Selvaraj D; Venkatachalam S; Selvaraj J; Sankar V; Natarajan J
    Int J Biol Macromol; 2024 Nov; 279(Pt 1):135487. PubMed ID: 39349339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance.
    Liu M; Chen D; Wang C; Chen X; Wen Z; Cao Y; He H
    J Drug Target; 2015; 23(9):800-5. PubMed ID: 25766079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
    Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
    J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.